3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Burkitt Lymphoma
9
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
2
Lymphoma, Large B-Cell, Diffuse
2
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Plasmablastic Lymphoma
1
Multiple Myeloma
1
Lymphoma, T-Cell
1
Lymphoma, Follicular
1
Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
1
Leukemia, Biphenotypic, Acute
1
Down Syndrome
1
Interventions
venetoclax
26
Cytarabine
23
Azacitidine
22
Specimen Handling
20
fludarabine
14
Biopsy
12
Injections
11
Cyclophosphamide
11
fludarabine phosphate
10
Daunorubicin
10
decitabine and cedazuridine drug combination
8
Whole-Body Irradiation
8
CPX-351
8
Mycophenolic Acid
7
ivosidenib
6
Tacrolimus
6
Idarubicin
6
Granulocyte Colony-Stimulating Factor
6
Gemtuzumab
6
Busulfan
6
enasidenib
5
Melphalan
5
Filgrastim
5
Etoposide
5
Cyclosporine
5
ruxolitinib
4
gilteritinib
4
X-Rays
4
Stem Cell Transplantation
4
Peripheral Blood Stem Cell Transplantation
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia, Myeloid, Acute
×
prednylidene
×
30 days
×
Clear all
No trials found.